In fact, FIB-4 and AFP decreased and albumin and PT improved from baseline to EOT and SVR12; thus, achievement of SVR may have a strong impact on the development of HCC by improving liver fibrosis and inflammation. The gene discussed is AFP; the disease is hepatocellular carcinoma.